Over the past two years, the Fridley, Minn.-based Medtronic Inc. (NYSE:MDT) has purchased nine companies: $700 million for CoreValve Inc., $370 million for ATS Medical Inc. and $123 million for Osteotech Inc., to name a few.
Yet the company has had little to show for its acquisitions. Since January, Medtronic shares have fallen nearly 25 percent to $34.